{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:23:04Z","timestamp":1791724984304,"version":"4.3.4"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"am","delay-in-days":330,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ijbiomac.2023.123367","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:07:23Z","timestamp":1674266843000},"page":"123367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Snake venom, a potential treatment for melanoma. A systematic review"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3827-2859","authenticated-orcid":false,"given":"Tatiane Senna","family":"Bialves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio L.Q.","family":"Bastos Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2100-1614","authenticated-orcid":false,"given":"Marcos Freitas","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Tew","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.123367_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejcb.2014.01.002","article-title":"Metalloproteinases in melanoma","volume":"93","author":"Moro","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0010","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","article-title":"Cell adhesion in cancer: beyond the migration of single cells","volume":"295","author":"Janiszewska","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0015","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/cancers13092024","article-title":"From proteomic mapping to invasion-metastasis-cascade systemic biomarkering and targeted drugging of mutant braf-dependent human cutaneous melanomagenesis","volume":"13","author":"Giannopoulou","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0030","first-page":"1","article-title":"Molecular principles of metastasis: a hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0035","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMra2034861","article-title":"Recent advances in the treatment of melanoma","volume":"384","author":"Curti","year":"2021","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0040","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1101\/gad.333864.119","article-title":"Targeted chemotherapy overcomes drug resistance in melanoma","volume":"34","author":"Yue","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.102995","article-title":"Metabolic rewiring in melanoma drug-resistant cells","volume":"153","author":"Bristot","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature25187","article-title":"High response rate to PD-1 blockade in desmoplastic melanomas","volume":"553","author":"Eroglu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.addr.2017.09.016","article-title":"Targeted drug delivery to melanoma","volume":"127","author":"Liu","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0060","series-title":"UCLA UCLA Previously Published Works Title Targeted Agents And Immunotherapies: Optimizing Outcomes in Melanoma","author":"Luke","year":"2017"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0065","series-title":"Surg. (United States)","article-title":"Evaluating the quality of reporting of melanoma prediction models","author":"Jiang","year":"2020"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0070","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0075","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/17460441.2021.1922386","article-title":"Advances in venom peptide drug discovery: where are we at and where are we heading?","volume":"16","author":"Smallwood","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114096","article-title":"Animal toxins \u2014 nature's evolutionary-refined toolkit for basic research and drug discovery","volume":"181","author":"Herzig","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-9845-6_1","article-title":"Snake- and spider-venom-derived toxins as lead compounds for drug development","author":"Lazarovici","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0090","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biocel.2018.09.011","article-title":"Snake venom components in medicine: from the symbolic rod of Asclepius to tangible medical research and application","volume":"104","author":"Estev\u00e3o-Costa","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215148","article-title":"Targeting TGF-\u03b2-mediated SMAD signaling pathway via novel recombinant cytotoxin II: a potent protein from Naja naja oxiana venom in melanoma","volume":"25","author":"Derakhshani","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105327","article-title":"Venom peptides in cancer therapy: an updated review on cellular and molecular aspects","volume":"164","author":"Mirzaei","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0105","article-title":"Putting the brakes on tumorigenesis with snake venom toxins: new molecular insights for cancer drug discovery","author":"Urra","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12040255","article-title":"Hitchhiking with nature: snake venom peptides to fight cancer and superbugs","volume":"12","author":"P\u00e9rez-Peinado","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10090346","article-title":"Snake venoms in cancer therapy: past, present and future","volume":"10","author":"Li","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0120","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.bmc.2017.09.029","article-title":"Peptide therapeutics from venom: current status and potential","volume":"26","author":"Pennington","year":"2018","journal-title":"<sb:contribution><sb:title>Bioorg. <\/sb:title><\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>Med. Chem.<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0125","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/203639","article-title":"Antitumoral activity of snake venom proteins: new trends in cancer therapy","volume":"2014","author":"Calderon","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0130","series-title":"King2011","first-page":"1469","author":"King","year":"2011"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23030692","article-title":"Anticancer activity of toxins from bee and snake venom-an overview on ovarian cancer","volume":"23","author":"Moga","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/toxins13050337","article-title":"Bee venom components as therapeutic tools against prostate cancer","volume":"13","author":"Badawi","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0145","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3389\/fphar.2020.01132","article-title":"From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery","volume":"11","author":"de C.F. Bordon","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0150","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1021\/acs.orglett.1c03112","article-title":"Total synthesis of the spider-venom peptide Hi1a","volume":"23","author":"Duggan","year":"2021","journal-title":"Org. Lett."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0155","article-title":"The effects of vesicle toxin from the sea anemone Bunodosoma cangicum on the behavior of a freshwater shrimp, Palaemon argentinus, and shore crab, Neohelice granulata","volume":"242","author":"Bastos Junior","year":"2021","journal-title":"Comp. Biochem. Physiol.CToxicol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0160","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/med.21800","article-title":"Discovery of KV1.3 ion channel inhibitors: medicinal chemistry approaches and challenges","volume":"41","author":"Gubi\u010d","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0165","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.7150\/jca.15309","article-title":"Effects of animal venoms and toxins on hallmarks of cancer","volume":"7","author":"Chaisakul","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0170","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3390\/pharmaceutics13122144","article-title":"Phyto-phospholipid conjugated scorpion venom nanovesicles as promising carrier that improves efficacy of thymoquinone against adenocarcinoma human alveolar basal epithelial cells","volume":"13","author":"Asfour","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0175","article-title":"Therapeutic potential of bee and scorpion venom phospholipase A2 (PLA2): a narrative review","author":"Soltan-Alinejad","year":"2021","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9080517","article-title":"Melittin from apis florea venom as a promising anticancer agent","volume":"9","author":"Sangboonruang","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41598-017-07082-2","article-title":"Antitumoral effects of \u03b3cdcPLI, a PLA 2 inhibitor from Crotalus durissus collilineatus via PI3K\/Akt pathway on MDA-MB-231 breast cancer cell","volume":"7","author":"Gimenes","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0190","first-page":"161","article-title":"Targeted drug delivery to melanoma","volume":"127","author":"Smallwood","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0195","doi-asserted-by":"crossref","DOI":"10.1590\/1678-9199-jvatitd-2020-0066","article-title":"Design, synthesis, and evaluation of Bothrops venom serine protease peptidic inhibitors","volume":"27","author":"da Silva","year":"2021","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0200","first-page":"600","article-title":"Macrovipecetin, a C-type lectin from Macrovipera lebetina venom, inhibits proliferation migration and invasion of SK-MEL-28 human melanoma cells and enhances their sensitivity to cisplatin","volume":"2018","author":"Hammouda","year":"1862","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1517\/13543784.2011.602064","article-title":"Crotamine toxicity and efficacy in mouse models of melanoma","volume":"20","author":"Pereira","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxicon.2014.02.018","article-title":"A lectin from Bothrops leucurus snake venom raises cytosolic calcium levels and promotes B16\u2013F10 melanoma necrotic cell death via mitochondrial permeability transition","volume":"82","author":"Aranda-Souza","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0225","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.bmc.2004.03.049","article-title":"Platelet aggregation and antibacterial effects of an L-amino acid oxidase purified from Bothrops alternatus snake venom","volume":"12","author":"St\u00e1beli","year":"2004","journal-title":"<sb:contribution><sb:title>Bioorg. <\/sb:title><\/sb:contribution><sb:host><sb:issue><sb:series><sb:title>Med. Chem.<\/sb:title><\/sb:series><\/sb:issue><\/sb:host>"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1570-9639(03)00232-2","article-title":"Lebecetin, a potent antiplatelet C-type lectin from Macrovipera lebetina venom","volume":"1651","author":"Sarray","year":"2003","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijbiomac.2019.05.164","article-title":"Antitumor and antimetastatic effects of PLA2-BthTX-II from Bothrops jararacussu venom on human breast cancer cells","volume":"135","author":"de Vasconcelos Azevedo","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0240","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S2221-1691(13)60042-8","article-title":"Therapeutic potential of snake venom in cancer therapy: current perspectives","volume":"3","author":"Vyas","year":"2013","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114149","article-title":"Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: a review","volume":"181","author":"Sch\u00f6nthal","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0250","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/pr901128x","article-title":"The venomics of Bothrops alternatus is a pool of acidic proteins with predominant hemorrhagic and coagulopathic activities","volume":"9","author":"\u00d6hler","year":"2010","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0255","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.toxicon.2005.02.012","article-title":"Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases","volume":"45","author":"Fox","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0260","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ijbiomac.2017.01.131","article-title":"Isolation and characterization of a novel metalloprotease inhibitor from Bothrops alternatus snake serum","volume":"98","author":"Palacio","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0265","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/391389","article-title":"Antitumoral potential of Tunisian snake venoms secreted phospholipases A2","volume":"2013","author":"Zouari-Kessentini","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0270","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/acs.jproteome.9b00120","article-title":"Comprehensive study of the proteome and transcriptome of the venom of the most venomous European viper: discovery of a new subclass of ancestral snake venom metalloproteinase precursor-derived proteins","volume":"18","author":"Leonardi","year":"2019","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0275","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fevo.2019.00218","article-title":"Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis","volume":"7","author":"Ferraz","year":"2019","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0280","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/labinvest.2009.137","article-title":"CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venom-derived phospholipases A2, inhibit angiogenesis both in vitro and in vivo","volume":"90","author":"Kessentini-Zouari","year":"2010","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0285","first-page":"3476","article-title":"Biochemical and pharmacological properties of a new thrombin-like serine protease (Russelobin) from the venom of Russell's Viper (Daboia russelii russelii) and assessment of its therapeutic potential","volume":"2013","author":"Mukherjee","year":"1830","journal-title":"Biochim. Biophys. Acta,Gen. Subj."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.toxicon.2016.11.001","article-title":"Serine proteinases from Bothrops snake venom activates PI3K\/Akt mediated angiogenesis","volume":"124","author":"Bhat","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0295","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1357-2725(97)00024-1","article-title":"Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah)","volume":"29","author":"Ahn","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0300","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/675985","article-title":"State of the art in the studies on crotamine, a cell penetrating peptide from South American rattlesnake","volume":"2014","author":"Kerkis","year":"2014","journal-title":"Biomed. Res.Int."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0305","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1002\/ijc.23777","article-title":"Angiostatic activity of obtustatin as \u03b11\u03b21 integrin inhibitor in experimental melanoma growth","volume":"123","author":"Brown","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxicon.2018.12.005","article-title":"Leucurogin and melanoma therapy","volume":"159","author":"Almeida","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0315","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijbiomac.2016.04.008","article-title":"The disintegrin tzabcanin inhibits adhesion and migration in melanoma and lung cancer cells","volume":"88","author":"Saviola","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12020102","article-title":"Isolation of an anti\u2013tumour disintegrin: Dabmaurin\u20131, a peptide Lebein\u20131\u2013Like, from Daboia mauritanica venom","volume":"12","author":"Chalier","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0325","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.toxicon.2011.02.014","article-title":"Anti-metastatic activity of the recombinant disintegrin, r-mojastin 1, from the mohave rattlesnake","volume":"57","author":"Lucena","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0330","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10616-014-9820-2","article-title":"Evaluation of cytotoxic activities of snake venoms toward breast (MCF-7) and skin cancer (A-375) cell lines","volume":"68","author":"Bradshaw","year":"2016","journal-title":"Cytotechnology"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0335","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.toxicon.2011.02.002","article-title":"Recombinant snake venom cystatin inhibits the growth, invasion and metastasis of B16F10 cells and MHCC97H cells in vitro and in vivo","volume":"57","author":"Xie","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.028","article-title":"BF-30 selectively inhibits melanoma cell proliferation via cytoplasmic membrane permeabilization and DNA-binding in vitro and in B16F10-bearing mice","volume":"707","author":"Wang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0345","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.toxicon.2014.10.020","article-title":"Toxins and drug discovery","volume":"92","author":"Harvey","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0350","first-page":"13","article-title":"Special technical feature venoms to drugs: translating venom peptides into therapeutics","volume":"44","author":"King","year":"2013","journal-title":"Aust. Biochem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0355","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-year outcomes with dabrafenib plus trametinib in metastatic melanoma","volume":"381","author":"Robert","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105757","article-title":"C-phycocyanin decreases proliferation and migration of melanoma cells: in silico and in vitro evidences","volume":"122","author":"Salgado","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0365","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.13005\/bpj\/2018","article-title":"In-silico analysis to determine the efficient drug for malignant melanoma using molecular dynamics","volume":"13","author":"Pallavi","year":"2020","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0370","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3390\/biomedicines9101375","article-title":"Synthesis, in silico study, and anti-cancer activity of thiosemicarbazone derivatives","volume":"9","author":"Sibuh","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0375","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1021\/jm300126x","article-title":"Design and synthesis of novel DFG-Out RAF\/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors. 1. Exploration of [5,6]-fused bicyclic scaffolds","volume":"55","author":"Okaniwa","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0380","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/molecules27030917","article-title":"A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of vieloplain F from Xylopia vielana targeting B-Raf kinase","volume":"27","author":"Ul Hassan","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0385","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.matbio.2013.01.001","article-title":"Inhibition of integrins \u03b1v\/\u03b15-dependent functions in melanoma cells by an ECD-disintegrin acurhagin-C","volume":"32","author":"Shih","year":"2013","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0390","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/excr.1995.1266","article-title":"Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis","volume":"219","author":"Morris","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0395","series-title":"Regulated cell death and adaptive stress responses To cite this version: HAL Id: hal-01301985 Regulated cell death and adaptive stress responses","author":"Galluzzi","year":"2016"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0400","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/cdd.2014.137","article-title":"Essential versus accessory aspects of cell death: recommendations of the NCCD 2015","volume":"22","author":"Galluzzi","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0405","doi-asserted-by":"crossref","first-page":"541","DOI":"10.21873\/anticanres.13146","article-title":"Integrin as a molecular target for anti-cancer approaches in lung cancer","volume":"39","author":"Aksorn","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0410","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0415","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","article-title":"Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment","volume":"10","author":"Harjunp\u00e4\u00e4","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0420","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/ATVBAHA.116.307610","article-title":"Endothelial cell junctional adhesion molecules","volume":"36","author":"Reglero-Real","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0425","series-title":"Beyond E-cadherin: roles of other cadherin superfamily members in cancer","author":"van Roy","year":"2014"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0430","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.21873\/invivo.12385","article-title":"Adhesion molecules in non-melanoma skin cancers: a comprehensive review","volume":"35","author":"Pogorzelska-Dyrbus","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0435","first-page":"M321","article-title":"Cell adhesion molecules","volume":"49","author":"Freemont","year":"1996","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0440","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/cancers11030311","article-title":"Oncogenic deregulation of cell adhesion molecules in leukemia","volume":"11","author":"Windisch","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0445","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/toxins2112606","article-title":"Snake venom disintegrins and cell migration","volume":"2","author":"Selistre-de-Araujo","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0450","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0455","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0460","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/exd.14023","article-title":"Activation of human vascular endothelium in melanoma metastases induces ICAM-1 and E-selectin expression and results in increased infiltration with effector lymphocytes","volume":"28","author":"Weishaupt","year":"2019","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/738137","article-title":"Integrin signaling, cell survival, and anoikis: distinctions, differences, and differentiation","volume":"2011","author":"Vachon","year":"2011","journal-title":"J. Signal Transduct."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/306879","article-title":"Anoikis resistance: an essential prerequisite for tumor metastasis","volume":"2012","author":"Kim","year":"2012","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0480","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1172\/JCI116007","article-title":"Human melanoma cells derived from lymphatic metastases use integrin \u03b1v\u03b23 to adhere to lymph node vitronectin","volume":"90","author":"Nip","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0485","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0490","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-13-1742","article-title":"\u03b21 integrin: critical path to antiangiogenic therapy resistance and beyond","volume":"74","author":"Jahangiri","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0495","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial-mesenchymal transition","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0500","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1242\/jcs.000455","article-title":"Cadherin switching","volume":"121","author":"Wheelock","year":"2008","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0505","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.tips.2012.04.002","article-title":"Integrins as therapeutic targets","volume":"33","author":"Goodman","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0510","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","article-title":"Integrins: versatility, modulation, and signaling in cell adhesion","volume":"69","author":"Hynes","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0515","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrc1817","article-title":"New roles for integrins in squamous-cell carcinoma","volume":"6","author":"Janes","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0520","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI114379","article-title":"Localization of integrin receptors for fibronectin, collagen, and laminin in human skin. Variable expression in basal and squamous cell carcinomas","volume":"84","author":"Peltonen","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0525","doi-asserted-by":"crossref","first-page":"31041","DOI":"10.1074\/jbc.M400024200","article-title":"R-cadherin influences cell motility via rho family GTPases *","volume":"279","author":"Johnson","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3181\/00379727-195-43129B","article-title":"Disintegrins: a family of lntegrin inhibitory","volume":"195","author":"Gould","year":"1990","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0535","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1111\/j.1742-4658.2008.06466.x","article-title":"Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity","volume":"275","author":"Fox","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0540","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0076-6879(95)48023-4","article-title":"Snake venom metalloendopeptidases: reprolysins","volume":"248","author":"Bjarnason","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0545","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ymthe.2016.11.002","article-title":"Systemic delivery of tumor-targeted bax-derived membrane-active peptides for the treatment of melanoma tumors in a humanized SCID mouse model","volume":"25","author":"Karageorgis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0550","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cancers9090110","article-title":"Integrins as therapeutic targets: successes and cancers","volume":"9","author":"Raab-Westphal","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0555","doi-asserted-by":"crossref","first-page":"18006","DOI":"10.18632\/aging.203309","article-title":"Implication of integrin \u03b12\u03b21 in senescence of SK-Mel-147 human melanoma cells","volume":"13","author":"Kozlova","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0560","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.20160831","article-title":"Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses","volume":"214","author":"Kwan","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0565","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.biochi.2012.04.020","article-title":"Blocking \u03b1v\u03b23 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells","volume":"94","author":"Montenegro","year":"2012","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073366","article-title":"Exogenous integrin \u03b1IIb\u03b23 inhibitors revisited: past, present and future applications","volume":"22","author":"van den Kerkhof","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0575","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0580","series-title":"fibronectin receptor iso-antagonists from Trimeresurus elegans venom","first-page":"775","volume":"782","author":"Scaloni","year":"1996"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0585","first-page":"177","article-title":"New insights on disintegrin-receptor interactions: eristostatin and melanoma cells","volume":"31","author":"McLane","year":"2001","journal-title":"Haemostasis"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0590","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2012.10.011","article-title":"Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions","volume":"61","author":"Hailey","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0595","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/excr.1997.3821","article-title":"The disintegrin eristostatin interferes with integrin \u03b14\u03b21 function and with experimental metastasis of human melanoma cells","volume":"238","author":"Danen","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0600","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10585-007-9101-y","article-title":"A novel \u03b1v\u03b23-blocking disintegrin containing the RGD motive, DisBa-01, inhibits bFGF-induced angiogenesis and melanoma metastasis","volume":"25","author":"Ramos","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0605","first-page":"4993","article-title":"Contortrostatin, a snake venom disintegrin, inhibits \u03b21 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis","volume":"54","author":"Trikha","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0610","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.8.15.8999","article-title":"Effect of VP12 and viperistatin on inhibition of collagen receptors-dependent melanoma metastasis","volume":"8","author":"Staniszewska","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0615","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00204-008-0358-y","article-title":"Colombistatin: a disintegrin isolated from the venom of the South American snake (bothrops colombiensis) that effectively inhibits platelet aggregation and SK-mel-28 cell adhesion","volume":"83","author":"S\u00e1nchez","year":"2009","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0620","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.toxicon.2007.07.016","article-title":"Effect of RGD-disintegrins on melanoma cell growth and metastasis: involvement of the actin cytoskeleton, FAK and c-Fos","volume":"50","author":"Oliva","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0625","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.biochi.2014.10.010","article-title":"Isolation and characterization of four medium-size disintegrins from the venoms of Central American viperid snakes of the genera Atropoides, Bothrops, Cerrophidion and Crotalus","volume":"107","author":"Angulo","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0630","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2009.05.012","article-title":"Lebectin increases N-cadherin-mediated adhesion through PI3K\/AKT pathway","volume":"285","author":"Sarray","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0635","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.toxicon.2012.03.011","article-title":"Anti-invasive and anti-adhesive activities of a recombinant disintegrin, r-viridistatin 2, derived from the prairie rattlesnake (Crotalus viridis viridis)","volume":"60","author":"Lucena","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0640","first-page":"1051","article-title":"A cell cycle hypothesis of cooperative oncogenesis (review)","volume":"30","author":"Delaval","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0645","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bcp.2010.04.029","article-title":"Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail","volume":"80","author":"Inamdar","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0650","first-page":"3883","article-title":"BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma","volume":"63","author":"Dong","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0655","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nature14982","article-title":"RAF inhibitors that evade paradoxical MAPK pathway activation","volume":"526","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0660","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1089\/ars.2011.4085","article-title":"Mitochondrial regulation of cell cycle and proliferation","volume":"16","author":"Arciuch","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0665","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0670","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090783","article-title":"Natural compounds' activity against cancer stem-like or fast-cycling melanoma cells","volume":"9","author":"Sztiller-Sikorska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0675","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8070206","article-title":"Lebein, a snake venom disintegrin, induces apoptosis in human melanoma cells","volume":"8","author":"Hammouda","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0680","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1158\/1535-7163.MCT-15-0617","article-title":"A novel RAF kinase inhibitor with DFG-out-binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation","volume":"15","author":"Waizenegger","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0685","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fmolb.2020.00154","article-title":"Current state of target treatment in BRAF mutated melanoma","volume":"7","author":"Tanda","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0690","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fimmu.2019.00990","article-title":"Combination of immunotherapy with targeted therapy: theory and practice in metastatic melanoma","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0695","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0700","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-013-0095-2","article-title":"Dabrafenib: first global approval","volume":"73","author":"Ballantyne","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0705","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0710","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0021-9258(18)54041-2","article-title":"Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms*","volume":"268","author":"Scarborough","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0715","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0046-8177(99)90202-2","article-title":"Progression-related expression of \u03b23 integrin in melanomas and nevi","volume":"30","author":"Van Belle","year":"1999","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0720","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1172\/JCI115811","article-title":"Involvement of integrin alpha V gene expression in human melanoma tumorigenicity","volume":"89","author":"Felding-Habermann","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0725","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijbiomac.2018.02.063","article-title":"Purification of a fragment obtained by autolysis of a PIIIb-SVMP from Bothrops alternatus venom","volume":"113","author":"Van de Velde","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0730","series-title":"2000 integrins \u03b1v\u03b23 and \u03b1v\u03b25 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.pdf","author":"Erdreich-Epstein","year":"2000"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2010.09.001","article-title":"Gene expression in SK-mel-28 human melanoma cells treated with the snake venom jararhagin","volume":"57","author":"Klein","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-446","article-title":"Antiproliferative effect of the Jararhagin toxin on B16F10 murine melanoma","volume":"14","author":"Maria","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0745","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0041-0101(01)00275-6","article-title":"Inhibition of melanoma cells tumorigenicity by the snake venom toxin jararhagin","volume":"40","author":"Corr\u00eaa","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0750","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2016.09.007","article-title":"Expression, purification, and analysis of three recombinant ECD disintegrins (r-colombistatins) from P-III class snake venom metalloproteinases affecting platelet aggregation and SK-MEL-28 cell adhesion","volume":"122","author":"Suntravat","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0755","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.18632\/oncotarget.27839","article-title":"Alphastatin-C a new inhibitor of endothelial cell activation is a pro-arteriogenic agent in vivo and retards B16\u2013F10 melanoma growth in a preclinical model","volume":"11","author":"Ferreira","year":"2020","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0760","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.toxicon.2014.04.010","article-title":"Lebecin, a new C-type lectin like protein from Macrovipera lebetina venom with anti-tumor activity against the breast cancer cell line MDA-MB231","volume":"86","author":"Jebali","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0765","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/ijms21062167","article-title":"Computational study on the effect of inactivating\/activating mutations on the inhibition of MEK1 by trametinib","volume":"21","author":"Zhu","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20061100","article-title":"Cell-penetrating peptides and antimicrobial peptides: how different are they?","volume":"399","author":"Henriques","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0775","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15216540500494508","article-title":"Properties of cell penetrating peptides (CPPs)","volume":"58","author":"Kerkis","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0780","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.toxicon.2008.06.029","article-title":"Cytotoxic effects of crotamine are mediated through lysosomal membrane permeabilization","volume":"52","author":"Hayashi","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0785","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00726-017-2513-3","article-title":"Oral treatment with a rattlesnake native polypeptide crotamine efficiently inhibits the tumor growth with no potential toxicity for the host animal and with suggestive positive effects on animal metabolic profile","volume":"50","author":"Campeiro","year":"2018","journal-title":"Amino Acids"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0790","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00210-021-02103-4","article-title":"Acute toxicity, antinociceptive, and anti-inflammatory activities of the orally administered crotamine in mice","volume":"394","author":"Moreira","year":"2021","journal-title":"Naunyn Schmiedebergs Arch. Pharmakol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0795","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00109-020-01975-y","article-title":"Biophysical and pharmacological characterization of a full-length synthetic analog of the antitumor polypeptide crotamine","volume":"98","author":"de Carvalho Porta","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0800","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0041-0101(02)00102-2","article-title":"Snake venom L-amino acid oxidases","volume":"40","author":"Du","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0805","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijbiomac.2016.07.022","article-title":"Mechanism of the cytotoxic effect of L-amino acid oxidase isolated from Bothrops alternatus snake venom","volume":"92","author":"Ribeiro","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0810","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.toxicon.2009.01.003","article-title":"Two purified and characterized phospholipases A2 from Cerastes cerastes venom, that inhibit cancerous cell adhesion and migration","volume":"53","author":"Zouari-Kessentini","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0815","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxicon.2019.06.220","article-title":"Cytotoxicity of Nubein6.8 peptide isolated from the snake venom of Naja nubiae on melanoma and ovarian carcinoma cell lines","volume":"168","author":"Abdel-Ghani","year":"2019","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0820","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/cancers11070978","article-title":"Are integrins still practicable targets for anti-cancer therapy?","volume":"11","author":"Alday-Parejo","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0825","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cellbi.2006.11.007","article-title":"Antitumor effects of cationic synthetic peptides derived from Lys49 phospholipase A2 homologues of snake venoms","volume":"31","author":"Araya","year":"2007","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0830","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.toxicon.2011.01.007","article-title":"Functional analysis of a recombinant PIII-SVMP, GST-acocostatin; an apoptotic inducer of HUVEC and HeLa, but not SK-mel-28 cells","volume":"57","author":"Teklemariam","year":"2011","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0835","first-page":"1","article-title":"Antitumor potential of the myotoxin BthTX-I from Bothrops jararacussu snake venom: evaluation of cell cycle alterations and death mechanisms induced in tumor cell lines","volume":"21","author":"da Silva","year":"2015","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0840","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1590\/S1678-91992012000100004","article-title":"Tumor cytotoxicity of leucurolysin-B, a P-III snake venom metalloproteinase from Bothrops leucurus","volume":"18","author":"Gabriel","year":"2012","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0845","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.toxicon.2011.12.002","article-title":"Recombinant rubistatin (r-Rub), an MVD disintegrin, inhibits cell migration and proliferation, and is a strong apoptotic inducer of the human melanoma cell line SK-mel-28","volume":"59","author":"Carey","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0850","first-page":"6458","article-title":"Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0855","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40409-016-0061-z","article-title":"Anticancer properties of phospholipase A2 from Daboia siamensis venom on human skin melanoma cells","volume":"22","author":"Khunsap","year":"2016","journal-title":"J. Venom. Anim. Toxins Incl. Trop. Dis."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0860","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF -mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0865","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cels.2018.06.002","article-title":"Dissecting RAF inhibitor resistance by structure-based modeling reveals ways to overcome oncogenic RAS signaling","volume":"7","author":"Rukhlenko","year":"2018","journal-title":"Cell Syst."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0870","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/mol.59.5.1333","article-title":"Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective \u03b1v\/\u03b23 blockade of endothelial cells","volume":"59","author":"Yeh","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0875","first-page":"192","article-title":"Viper venom components affecting angiogenesis","volume":"31","author":"Huang","year":"2001","journal-title":"Haemostasis"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0880","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.toxicon.2003.10.023","article-title":"Purification, cloning and biological characterization of a novel disintegrin from Trimeresurus jerdonii venom","volume":"43","author":"Zhou","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0885","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0014-4827(91)90449-5","article-title":"Inhibition of murine melanoma cell-matrix adhesion and experimental metastasis by albolabrin, an RGD-containing peptide isolated from the venom of Trimeresurus albolabris","volume":"196","author":"Soszka","year":"1991","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0890","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/bbrc.2000.3130","article-title":"Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis","volume":"275","author":"Kang","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0895","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02253423","article-title":"Application of recombinant rhodostomin in studying cell adhesion","volume":"4","author":"Chang","year":"1997","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0900","author":"Sheu"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0905","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF02257966","article-title":"Triflavin, an Arg-Gly-Asp-containing peptide, inhibits B16\u2013F10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells","volume":"3","author":"Sheu","year":"1996","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0910","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.toxicon.2016.04.038","article-title":"Functional characterization of six aspartate (D) recombinant mojastin mutants (r-Moj): a second aspartate amino acid carboxyl to the RGD in r-Moj-D- peptides is not sufficient to induce apoptosis of SK-Mel-28 cells","volume":"118","author":"Ramos","year":"2016","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0915","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.toxicon.2006.12.013","article-title":"Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin","volume":"49","author":"Tian","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0920","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.matbio.2009.09.009","article-title":"Leberagin-C, a disintegrin-like\/cysteine-rich protein from Macrovipera lebetina transmediterranea venom, inhibits alphavbeta3 integrin-mediated cell adhesion","volume":"29","author":"Limam","year":"2010","journal-title":"Matrix Biol."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0925","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/labinvest.3700088","article-title":"Lebectin, a novel C-type lectin from Macrovipera lebetina venom inhibits integrin-adhesion, migration and invasion of human tumour cells","volume":"84","author":"Sarray","year":"2004","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0930","first-page":"4023","article-title":"The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation","volume":"19","author":"Pereira-Bittencourt","year":"1999","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0935","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/toxins5020203","article-title":"Interactions of PLA2-s from Vipera lebetina, Vipera berus berus and Naja naja oxiana venom with platelets, bacterial and cancer cells","volume":"5","author":"Samel","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0940","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CAD.0b013e32835f258d","article-title":"Recombinant snake venom metalloproteinase inhibitor BJ46A inhibits invasion and metastasis of B16F10 and MHCC97H cells through reductions of matrix metalloproteinases 2 and 9 activities","volume":"24","author":"Ji","year":"2013","journal-title":"AnticancerDrugs"},{"key":"10.1016\/j.ijbiomac.2023.123367_bb0945","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2007-1003568","article-title":"Antitumor action of crotalase, a defibrinogenating snake venom enzyme","volume":"12","author":"Markland","year":"1986","journal-title":"Semin. Thromb. Hemost."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023002532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023002532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:05:14Z","timestamp":1758881114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023002532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":188,"alternative-id":["S0141813023002532"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123367","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Snake venom, a potential treatment for melanoma. A systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123367"}}